Compare Adaptive Biotechnologies Corp (ADPT) vs F5 Inc (FFIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs F5 Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while F5 Inc trades at $415.62 (market cap $23.44B). The key difference: F5 Inc is far larger — about 5.8× Adaptive Biotechnologies Corp's market cap. Which is the better fit depends on your goals.
| ADPT | FFIV | |
|---|---|---|
Market Cap | $4.04B | $23.44B |
Sector | Health | Technology |
52-Week High | $25.45 | $431.26 |
52-Week Low | $12.30 | $223.99 |
Enterprise Value | $4.10B | $22.08B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About F5 Inc
F5 is a market leader in the application delivery controller market. The company sells products for networking traffic, security, and policy management. Its products ensure applications are safely routed in efficient manners within on-premises data centers and across cloud environments. More than half of its revenue is based on providing services, and its three customer verticals are enterprises, service providers, and government entities. The Seattle-based firm was incorporated in 1996 and generates sales globally.
Read more on FFIV →
